Category: Press Releases

Categories
In the News Latest News Press Releases Top Stories

Earth Science Tech Achieves Q1 Goal with Expansion of Executive Leadership Team

Leadership Success Skills Drawing Graphic Concept

Doral, FL, February 1, 2018 (GLOBE NEWSWIRE) – Earth Science Tech (OTC PINK: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces the appointments of a new chief sales officer (CSO), chief financial officer (CFO), and chief learning officer (CLO).

As part of ETST’s previously announced goals for the first quarter of 2018, the Company has expanded its core executive team to now include Jill Buzan as CSO, Wendell Hecker as CFO, and prior CSO Gabriel Aviles to the role of CLO to maximally leverage strengths and lead to bottom-line growth in 2018.

CSO Buzan, an established veteran of the natural product sales industry, began her successful career as a sales rep and broker in Florida in 1995. She has pioneered many brands and helped them grow and become leaders in the industry including Gaia Herbs, Natural-Immunogenics and Sunwarrior. She loves taking outstanding products to  market! Her passion since 1979 has been natural health and healing through food, supplements, exercise, lifestyle and helping others achieve their full potential on all levels, physically, emotionally, mentally and spiritually. Her sales strength, and financial success comes from this passion and using an education based and consultative sales approach with her customers. Her intention with ETST is to create a dynamic group of sales  people who, together, can make ETST the top-selling CDB company in the industry. Jill already has multiple chain store accounts lined up for the Company’s revamped line, which is launching within the first week of February.

Buzan states, “Having worked with so many budding natural products brands, I know what it takes for a company to find success in this market, and ETST has it. The executive team is motivated, hard-working, and talented. I will be building a strong sales team this year, and we envision opening a record number of new accounts in 2018.”

CFO Hecker achieved a Bachelor of Science in Accounting from New York University. Having spent more than 30 years at large corporations in New York and Florida, he brings to ETST extensive accounting experience. Hecker will ensure that the Company’s accounting follows best practices, keeps up-to-date, and increases transparency with investors as sales continue to increase. He will help also the Company maintain compliance when up-listed to the OTCQB exchange.

Hecker comments, “This company is on the cusp of increasing sales dramatically. It’s the right time to get the books in order and ensure compliance as the company grows and joins the QB Tier of the OTC Markets.”

Aviles, the Company’s current CSO, will transition to the role of CLO to help further educate store owners and clients, assist in the new foundation, and help build brand integrity. Aviles plans to publish articles, record informative videos, conduct webinars, attend conferences, and help educate the Company’s growing sales team to provide the informative service to accounts.

Aviles shares, “Education puts me in my element. While I enjoyed my time as the CSO, I feel I will have much more impact on helping the company grow as the CLO, and Ms. Buzan definitely has what it takes to lead our organization’s sales efforts to the next level.”

Nickolas S. Tabraue, ETST’s president, director and COO concludes, “I have been extremely fortunate to have found hard working like-minded individuals to work together and achieve our company’s overarching vision. The year has only just begun, and we are already looking very strong. I expect to have a lot of exciting updates to share with our stakeholders very soon.”

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit: www.earthsciencetech.com

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.EarthSciencePharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.CannabisThera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.KannaBidioiDInc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Dave Demarest (305) 546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305) 615-2118

Corporate Communications Contact: 
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Categories
In the News Latest News Marketing Press Releases

Earth Science Tech Appoints New Board Member, Mr. Avi Levy, Esq., to Develop Canadian Market

Doral, FL, January 09, 2018 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK: ETST) (“ETST” or, the “Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device R&D, is pleased to announce the appointment of Mr. Avi Levy, Esq. as the company’s legal consultant for Canadian activities.

With Mr. Levy’s expertise as a highly-regarded lawyer, the company plans to expand its business in Canada. Levy has been practicing law for over twenty-two years and has been involved in both criminal and civil law since the beginning of his practice. He started his career at one of the biggest law firms in Canada, where he worked in tax and estate law, dealing mostly with regulatory issues, and as a prosecutor. He went on to advise and act as general counsel to some of the biggest internet companies, in addition to top athletes and celebrities in the United States. Most recently, Mr. Levy established himself as an expert in the medical marijuana industry, representing some of Canada’s largest clinics and counseling them on regulatory and legal issues.

Mr. Levy will help the company apply for licenses to import its CBD-rich hemp oil into Canada, where it will be transformed and exported in bulk as raw hemp oil, or in individual ready-to-consume bottles. CBD-rich hemp oil is growing in popularity around the world, and ETST hopes to soon begin exporting from its Canadian facilities to various different countries. The company will also profit from the new Canadian market that is opening for cannabis edible products.

“We will be well prepared for that new market. We will manufacture and start to distribute our 3 new CBD-based nutraceutical products in USA in 2018 and in 2019, following our application to get a license to work with schedule II controlled substances,” said Mr. Levy, “We will develop new products with a mix of CBD and THC-rich cannabis oil. In Canada there will be a huge amount of production of dried cannabis herb, and we will profit from purchasing and transforming the excess stock these companies create.”

“We are very excited to welcome Mr. Avi Levy, Esq. to our board of directors,” said CEO & CSO, Michel Aubé, “He brings with him decades of experience in advising companies and individuals in rapid-growth environments, has personal connections to top brands and celebrities, and has worked directly with the cannabis industry. We can’t wait to explore the synergies we have with him, and watch our Canadian prospects grow.”

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the superior supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrate that we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil.

To learn more and to buy CBD Hemp Oil please visit: www.earthsciencetech.com

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.Earthsciencepharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.Cannabisthera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.kannabidioidinc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

 

Investor Relations Dave Demarest (305) 546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305) 615-2118

Categories
Cannabis Events In the News Latest News Press Releases Top Stories

EARTH SCIENCE TECH, INC. CELEBRATES THE END OF A YEAR OF MAJOR ACHIEVEMENTS AND LOOKS FORWARD TO A BANNER 2018

Doral, FL, Dec. 28, 2017 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK: ETST) (“ETST” or, the “Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, shares all the company’s achievements throughout 2017 and what’s to come 2018.

It would be easy to list all of the achievements of the past year, but impossible to squeeze them all into one announcement. However, there are some highlights that the company wishes to underscore as 2017 comes to a close.

“This past year was amazing,” stated Michel Aubé PhD, CEO and Chief Scientific Officer. “I am very enthusiastic about the start of the New Year with all that we accomplished in 2017. We implemented a development plan for the coming three years and opened new manufacturing and shipping facilities which position us perfectly to realize our long term vision. We have really built the foundation and infrastructure the company needs to succeed long-term. Fiscally, we began the process of up-listing from the Pink Sheet category to the OTCQB and we will complete this process early in 2018. This up-listing will bring aboard well-funded institutional investors and I feel that we are now on the way to becoming the next billion-dollar-in-capitalization company on the OTC Markets.”

At the beginning of the year, ETST finished populating its Scientific Advisory Council with a team of recognized scientists. The company also found the perfect research center to complete the development of the three nutraceuticals in ETST’s new-product pipeline and future projects.

January:

In January, Earth Science Tech signed a Marketing & Media Agreement with Pearls of Health and appointed Gabriel Aviles as Chief Sales Officer (CSO).

Since the addition of Gabriel Aviles as CSO, the growth of the market has been appreciable. New partnerships with multiple distributors of dietary supplement stores all across USA have drastically increased the company’s sales and exposure. Gabriel Aviles adds, “My team of representatives already have the best-quality, full spectrum industrial hemp oil and derived products on the market and our product offerings will become still better with the launch of the incredible products we are developing. In 2017 we nearly doubled our sales over 2016 and sales will continue to skyrocket over the few next years both in the USA alone, and in the new markets we will open in neighbouring and overseas countries.”

January also saw the launch of a chocolate product manufactured through a joint venture with Karmavore SuperFood, which was a great success, complimenting the company’s CBD line. As well signing Sergio Castillo as the company’s Chief Marketing Officer, enhancing ETST’s image and achieving successful brand exposure. The market for products derived from hemp oil is growing and ETST will continue to surprise consumers with new innovative recipes in 2018.

February:

In February the company launched Cannabis Therapeutic Inc., a new division whose purpose is to develop proprietary cannabinoid-based nutraceuticals and pharmaceutical products using Earth Science Tech’s existing Cannabis CBD Patent, IP, and future technologies to be developed. The company engaged to create two new Cannabinoid-based pharmaceutical drugs and three new advanced Cannabinoid-based nutraceutical products in collaboration with Smart Medicine, Inc. an independent laboratory based in Le Centre Québecois d’Innovation en Biotechnologie (CQIB) in Laval, Québec

ETST also acquired Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada. This acquisition is allowing the company access to government grants offered to companies for innovation in the pharmaceutical industry. Applications for grant have already been files and the company anticipates announcing the granting of the first request in Q1 2018. The existence of this Canadian division will help extend the collaboration between ETST resources in Canada and USA, and allow the company to have up to 50% of all R&D expenditures covered by grants from governmental or private sources.

March:

In Marsh ETST commenced leasing the required manufacturing facility for the production of the MSN-2 medical device and began the first round of negotiations with foreign health authorities for the MSN-2’s commercialization. This product will be launched in select countries in 2018, which will be the beginning of the success story for this unique tool that will allow women to take their health needs in their own hands. It will allow women to protect themselves and their future babies from Chlamydia and other sexually transmitted infections (STI). ETST is proud to participate in the fight to counter the spread of STI and their devastating effects on the sexual organs of women.

April:

May:

At the end of May, ETST launched several new products, including Strawberry Orange Blossom CBD oil, CBD Organic Chocolate line, and Pet CBD oil; ETST’s management team found an opportunity to step into the recreational vape/smoke market by partnering with Varsity Group, LLC; a Kanna ingredient based e-liquid company.

June:

ETST launched it’s new wholly-owned subsidiary, KannaBidioid Inc., entering into a joint venture with Varsity Group, LLC. The new subsidiary is manufacturing and distributing vapes/e-liquids and gummy edibles to fulfill the product needs of vape/smoke shops. »

In June ETST signed an agreement with Absolu Communications, one of Canada’s most prestigious integrated web and communications companies, for the branding and rollout of ETST’s much-anticipated MSN-2 medical device. At year end, the branding – including the brand name, visual identity (logo, packaging, artwork), and marketing language around the new product are close to being announced. In 2018, Absolu will develop a secure transactional website for online sales, and then deliver a communications and marketing plan for the rollout of the new device.

August:

In august ETST signed an agreement with the Centre de Développement Bioalimentaire du Québec (CDBQ), a major force in the agro-food industry in Canada. Based in La Pocatière, Quebec, CDBQ specializes in helping companies develop the processes needed to take a prototype agro-food or nutraceutical product to industrial-scale production for the marketplace. CDBQ boasts a bio-food incubator, a 30,000 square foot $10 million facility that houses seven separate factories equipped with cutting-edge equipment and technology.

ETST signed a new partnership with Brazilian company, Bionatus. Inc., to participate in the manufacturing, distribution, and development of cannabis (CBD) products. With Bionatus, ETST is working to develop a treatment against asthma that will be unique and sold all across the USA in the near future. This market is very huge and the product will represent a new income stream.

September:

In September a strategic agreement was signed with Axcelon Biopolymers Corp. for the distribution of their Nanoderm™ medical device was signed. The agreement adds potential success to ETST’s foreign market development as – along with the MSN-2 medical device – ETST now has two medical devices to catch the eyes of foreign medical device distributors.

October:

In October ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device enters molecular diagnostic trials.

November

In November ETST began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula is based on industrial hemp CBD oil mixed with a known natural ingredient proven to help increase dopamine levels. The formula is expected to decrease cravings and the negative effects of withdrawal in addicts.

The company announced a new partnership agreement to develop the Vietnam market. Vietnam will join Djibouti and Morocco as the early launch markets for ETST medical devices while the company waits for regulatory permission to launch in North America.

The marketing efforts done in 2017 succeeded in significantly increasing the volume of sales in the USA and had a great exposure at ETST’s first expo. ETST will revamp its cannabinoids products in the beginning of 2018 to promote its full spectrum hemp oil products, which are now ready to explode on market. Everything is in place to satisfy the demands of the consumer market with it’s new major distributor.

December:

At year end, ETST has everything place to launch a Regulation A+ Tier 2 round of financing in 2018. The goal will be to raise $4 million to complete all the actual planned projects.

ETST’s president, Director, & COO ends the year with, “we have had a very successful year building ETST’s brand image, increasing exposure, building a solid team, and positioning ourselves for en explosive successful 2018. We plan on bringing three new officer positions to our growing company to increase effeminacy and continue our growth. Our audit is still being done and looks to be finalized very soon, our new product revamp is planned to launch mid-January, and our OTCB up-listing will take place along with the initiation of the regulation A+ Tier 2. We greatly appreciate all who have believed in our vision and I look forward on what 2018 has to come.”

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the superior supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed alongside the University of Central Oklahoma and DV Biologics laboratory, prove we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil.

To learn more and to buy CBD Hemp Oil please visit: www.earthsciencetech.com

View ETST’s accomplishments and reports on its High-Grade CBD Hemp Oil: (here)

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.Earthsciencepharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.Cannabisthera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by it’s unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.kannabidioidinc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Dave Demarest (305)-546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305)-615-2118

Categories
In the News Latest News Marketing Press Releases Top Stories

Earth Science Tech Signs Distribution Agreement with Mr. Checkout for its New CBD Product Revamp Starting in 2018

DISTRIBUTION Businessman touching a touch screen on blurred city background

Doral, FL, Dec. 13, 2017 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK:ETST) (“ETST” or “the Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, signs distribution agreement with Mr. Checkout, beginning in 2018, and coinciding with the company’s new CBD product revamp.

ETST looks to start the year strong, adding it’s first major distributor to the already strong and growing team of representatives across the U.S. The company currently has 10 active representatives opening and managing accounts across the states, one of which recently joined in December and immediately began bringing in a good number of chain stores. The representatives have been very successful with health food stores and clinics. ETST has signed a distribution agreement with Mr. Checkout to open and manage major retailers and stores within the U.S., which substantially expands the company’s reach.

Mr. Checkout, as featured on ABC’s Shark Tank, is a national group of independent distributors, full-line grocery distributes, and convenience stores. Mr. Checkout represents products in over 60 major retailers throughout the U.S. and approximately 55,000 stores. A few of Mr. Checkout’s accounts are Walgreens, CVS, Walmart, Wholefoods Market, and Target, just to name a few.

Gabriel Aviles, ETST’s Chief Sales Officer & Director states, “I feel that we have finally put together a solid productive team of representatives that we needed to continue expanding our presence in health shops and clinics. Now, with Mr. Checkout, we will be able to take our presence and sales to the next level, entering larger retailers and many stores. 2018 looks to be starting off very strong with our new product revamp, marketing and education strategy, and sales channel.”

ETST’s President, Director, & COO concludes with, “Gabriel has done a remarkable job building our sales team and expanding our presence across the U.S. I have no doubt that 2018 is going to be a solid year of growth for us, with all we have initiating as early as January alone, with our CBD products. Our MSN-2 medical device globalization strategy is still on track, and we are currently in talks with institutional investors thanks to our planned up-listing in Q1 2018. I plan on sharing further updates as they progress on the MSN-Medical device, IP patents, CBD based pharmaceutical generic drugs, and our new CBD formula opioid clinical trials as they progress.”

 

About Earth Science Tech (ETST)

Earth Science Tech has the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the world’s best supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed alongside the University of Central Oklahoma and DV Biologics laboratory, prove we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil.

To learn more and to buy CBD Hemp Oil please visit: www.earthsciencetech.com

View ETST’s accomplishments and reports on its High-Grade CBD Hemp Oil: (here)

 

About Earth Science Pharmaceutical

Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.Earthsciencepharmaceutical.com

 

About Cannabis Therapeutics

Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.Cannabisthera.com

 

About KannaBidioiD

KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by it’s unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.kannabidioidinc.com

 

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.

 

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Dave Demarest (305)-546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305)-615-2118
Categories
Hemp Oil In the News Latest News Marketing Press Releases Top Stories

ETST is starting the new year with a revamped CBD product packaging and marketing.

The ETST marketing team is always looking to keep our product marketing fresh and relevant in the current CBD market. Our team recently announced that it will steer the company’s branding in a new direction. Instead of labeling and marketing its products as, “High-Grade Hemp CBD Oil,” the company will start branding and marketing its products as, “High Grade Full Spectrum Cannabinoids,” in the beginning of 2018.

Our design team also has worked on new packaging designs for our line of products. The new designs kept the familiar blue and white color schemes but cleaned up the layout and added some detailed splash elements and icons to bring the design together.

See the designs below

 

 

ETST’s Chief Marketing Officer commented, “We did a lot of market research to see what the best angle to truly stand out in the growing CBD industry is through our accounts, representative feedback, and external brand analysis. I feel that marketing, HHigh-GradeFull Spectrum Cannabinoids’ will help ETST truly stand out. Soon, the market will be able to see that ETST is a true full spectrum CBD brand, especially with the cannabinoid complex listing under the supplement facts.”

Categories
Cannabis Events Latest News Press Releases

Earth Science Tech Announces a Suc-cessful Two-Day SOHO Expo

ETST Corporate Brand Well Received at EXPO; Opening New Accounts, Both Retail and Wholesale

Doral, FL, Dec. 05, 2017 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK: ETST) (“ETST” or “the Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, updates shareholders on the participated successful SOHO Expo, which was mentioned in early November (Earth Science Tech. Announces New Corporate Facility & participates in its First Trade Expo in December).

On December 2nd and 3rd, ETST participated at its first major show at the SOHO Expo in the Gaylord Palms Orlando Resort in Florida. “The event was a huge success, generating the additional exposure to expand the ETST territory.  We had the opportunity to open new retail and wholesale accounts, as well as speak to consumers directly to the advantages of the ETST product line,” stated Nickolas Tabraue ETST’s President, Director, & COO.

Gabriel Aviles, ETST’s Chief Sales Officer and Director shares, “On top of the countless new connections we made, thanks to the tremendous networking opportunities at the expo, we were able to directly add to our bottom line. The additional accounts we added during the expo will also create recurring revenue for us.”

Nickolas Tabraue, concludes with, “As we have been growing and evolving as a company, we have been working hard to revamp our products and develop a stronger marketing strategy. With the success we found this weekend, I would say our new developments are working. We are excited to start rolling out our CBD products across the nation, and to continue on the rapid growth trajectory we’ve set out on.”

 

About Earth Science Tech (ETST)

Earth Science Tech has the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the world’s best supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed alongside the University of Central Oklahoma and DV Biologics laboratory, prove we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil.

To learn more and to buy CBD Hemp Oil please visit: www.earthsciencetech.com

View ETST’s accomplishments and reports on its High-Grade CBD Hemp Oil: (here)

 

About Earth Science Pharmaceutical

Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.Earthsciencepharmaceutical.com

 

About Cannabis Therapeutics

Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.Cannabisthera.com

 

About KannaBidioiD

KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by it’s unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.kannabidioidinc.com

 

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.

 

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

 

Investor Relations Dave Demarest (305)-546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305)-615-2118